"Lymphatic Metastasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
| Descriptor ID |
D008207
|
| MeSH Number(s) |
C04.697.650.560 C23.550.727.650.560
|
| Concept/Terms |
Lymphatic Metastasis- Lymphatic Metastasis
- Lymphatic Metastases
- Metastases, Lymphatic
- Metastasis, Lymphatic
|
Below are MeSH descriptors whose meaning is more general than "Lymphatic Metastasis".
Below are MeSH descriptors whose meaning is more specific than "Lymphatic Metastasis".
This graph shows the total number of publications written about "Lymphatic Metastasis" by people in this website by year, and whether "Lymphatic Metastasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 5 | 5 |
| 1994 | 0 | 7 | 7 |
| 1995 | 0 | 6 | 6 |
| 1996 | 0 | 5 | 5 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 1 | 1 |
| 1999 | 2 | 5 | 7 |
| 2000 | 1 | 7 | 8 |
| 2001 | 1 | 10 | 11 |
| 2002 | 0 | 5 | 5 |
| 2003 | 1 | 7 | 8 |
| 2004 | 5 | 2 | 7 |
| 2005 | 3 | 5 | 8 |
| 2006 | 1 | 8 | 9 |
| 2007 | 0 | 11 | 11 |
| 2008 | 2 | 16 | 18 |
| 2009 | 2 | 11 | 13 |
| 2010 | 3 | 12 | 15 |
| 2011 | 0 | 7 | 7 |
| 2012 | 1 | 18 | 19 |
| 2013 | 3 | 19 | 22 |
| 2014 | 2 | 12 | 14 |
| 2015 | 0 | 13 | 13 |
| 2016 | 1 | 21 | 22 |
| 2017 | 2 | 14 | 16 |
| 2018 | 4 | 8 | 12 |
| 2019 | 6 | 11 | 17 |
| 2020 | 4 | 10 | 14 |
| 2021 | 1 | 5 | 6 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphatic Metastasis" by people in Profiles.
-
Programmed Death Ligand-1 Combined Positive Score Concordance and Interrater Reliability in Primary Tumors and Synchronous Lymph Node Metastases in Resected Cases of p16+ Oropharyngeal Squamous Cell Carcinoma. Arch Pathol Lab Med. 2023 04 01; 147(4):442-450.
-
Prognostic Significance of Size, Location, and Number of Lymph Node Metastases in Endometrial Carcinoma. Int J Gynecol Pathol. 2023 Jul 01; 42(4):376-389.
-
Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2022 Feb; 37(2):467-473.
-
Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects. Ann Surg. 2022 01 01; 275(1):e155-e162.
-
A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma. Int J Cancer. 2022 02 01; 150(3):450-460.
-
The Controversy of Lateral Aberrant Thyroid and the use of BRAF Immunostain. Int J Surg Pathol. 2022 Apr; 30(2):217-220.
-
Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers. Ultrasound Med Biol. 2021 08; 47(8):2193-2201.
-
Predicting Lymph Node Metastasis in Non-small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models. Chest. 2021 09; 160(3):1108-1120.
-
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas. Sci Adv. 2021 03; 7(13).
-
Occlusion of the internal jugular vein in differentiated thyroid carcinoma: Causes and diagnosis. Eur J Surg Oncol. 2021 Jul; 47(7):1552-1557.